ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,475, issued on Oct. 14, was assigned to Purdue Pharmaceutical Products LP (Stamford, Conn.).
"Hodgkin lymphoma therapy" was invented by Thomas Mehrling (Riehen, Switzerland), Rosaria De Filippi (Naples, Italy) and Antonio Pinto (Naples, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided a compound of formula I or a pharmacologically acceptable salt thereof for use in a method of treating Hodgkin lymphoma in a patient in need thereof comprising administering to said patient an effective amount of said compound of formula I or a pharmacologically acceptable salt thereof:a combination of said compound of formula I or a pharmaceutica...